Controversies and Disparities in the Management of Age-Related Macular Degeneration

Article Properties
  • Language
    English
  • Publication Date
    2023/01/05
  • Indian UGC (journal)
  • Refrences
    88
  • Aaron M. Fairbanks Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA ORCID (unauthenticated)
  • Deeba Husain Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA
Cite
Fairbanks, Aaron M., and Deeba Husain. “Controversies and Disparities in the Management of Age-Related Macular Degeneration”. Seminars in Ophthalmology, vol. 38, no. 2, 2023, pp. 134-42, https://doi.org/10.1080/08820538.2022.2152705.
Fairbanks, A. M., & Husain, D. (2023). Controversies and Disparities in the Management of Age-Related Macular Degeneration. Seminars in Ophthalmology, 38(2), 134-142. https://doi.org/10.1080/08820538.2022.2152705
Fairbanks AM, Husain D. Controversies and Disparities in the Management of Age-Related Macular Degeneration. Seminars in Ophthalmology. 2023;38(2):134-42.
Refrences
Title Journal Journal Categories Citations Publication Date
Phase 1 study of intravitreal gene therapy with ADVM-022 for neovascular AMD (OPTIC Trial) 2021
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy Archives of Ophthalmology 648 1984
Poorer Outcomes in Real-World Studies of Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration Ophthalmology
  • Medicine
  • Medicine: Ophthalmology
  • Medicine: Medicine (General)
11 2020
Variations and trends in global disease burden of age‐related macular degeneration: 1990‐2017

Acta Ophthalmologica
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
9 2020
Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration

European Journal of Ophthalmology
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
4 2020